Mycoplasma genitalium. If you haven’t heard of it, you’re not alone. But in spite of its status as an emerging pathogen, the rising prevalence, linkage to adverse reproductive outcomes, and evidence of antibiotic resistance of M. genitalium all underscore the need for improved awareness of this organism.
Mycoplasma genitalium: A Review of Current Issues and Challenges
Mycoplasma genitalium. If you haven’t heard of it, you’re not alone. But in spite of its status as an emerging pathogen, the rising prevalence, linkage to adverse reproductive outcomes, and evidence of antibiotic resistance of M. genitalium all underscore the need for improved awareness of this organism.
This case report and literature review examines current issues and challenges associated with this sexually transmitted infection (STI), to include:
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More